# A Two Chemoprophylaxis Approaches After Phacoemulsification Surgery

> **NCT03634852** · PHASE4 · COMPLETED · sponsor: **Suzan A Rattan** · enrollment: 1000 (actual)

## Conditions studied

- Endophthalmitis Postoperative

## Interventions

- **DRUG:** Moxifloxacin hydrochloride 0.5% eye drops
- **DRUG:** Dexamethasone 0.1% eye drops
- **DRUG:** Intracameral Moxifloxacin 0.1%
- **DRUG:** Subconjunctival Triamcinolone acetonide 4 mg /0.4 ml

## Key facts

- **NCT ID:** NCT03634852
- **Lead sponsor:** Suzan A Rattan
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-10-01
- **Primary completion:** 2018-02-01
- **Final completion:** 2018-02-01
- **Target enrollment:** 1000 (ACTUAL)
- **Last updated:** 2023-05-03

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03634852

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03634852, "A Two Chemoprophylaxis Approaches After Phacoemulsification Surgery". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT03634852. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*